Reinaldo De Menezes Martins

Manguinhos, RJ, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Validation of a yellow fever vaccine model using data from primary vaccination in children and adults, re-vaccination and dose-response in adults and studies with immunocompromised individuals.

Validation of a yellow fever vaccine model using data from primary vaccination in children and adults, re-vaccination and dose-response in adults and studies with immunocompromised individuals.

Journal: BMC bioinformatics
Published: October 21, 2020

17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil.

17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil.

Journal: Emerging infectious diseases
Published: July 13, 2019

Duration of post-vaccination humoral immunity against yellow fever in children.

Duration of post-vaccination humoral immunity against yellow fever in children.

Journal: Vaccine
Published: June 24, 2019

Duration of post-vaccination immunity to yellow fever in volunteers eight years after a dose-response study.

Duration of post-vaccination immunity to yellow fever in volunteers eight years after a dose-response study.

Journal: Vaccine
Published: March 13, 2018

Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data.

Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data.

Journal: Vaccine
Published: March 09, 2016

Serious adverse events associated with yellow fever vaccine.

Serious adverse events associated with yellow fever vaccine.

Journal: Human vaccines & immunotherapeutics
Published: June 20, 2015

Immunogenicity and safety of measles-mumps-rubella vaccine delivered by disposable-syringe jet injector in healthy Brazilian infants: a randomized non-inferiority study.

Immunogenicity and safety of measles-mumps-rubella vaccine delivered by disposable-syringe jet injector in healthy Brazilian infants: a randomized non-inferiority study.

Journal: Contemporary clinical trials
Published: August 07, 2014

17DD and 17D-213/77 yellow fever substrains trigger a balanced cytokine profile in primary vaccinated children.

17DD and 17D-213/77 yellow fever substrains trigger a balanced cytokine profile in primary vaccinated children.

Journal: PloS one
Published: June 25, 2012
Showing 1-8 of 8

Last Updated: 09/26/2026